Description
Zepbound uses the same active ingredient (tirzepatide) as Mounjaro®. It’s a dual-action GLP-1/GIP-receptor agonist that is approved by the FDA for people with obesity, or overweight plus a weight-related condition, along with diet and exercise changes.
How is Zepbound different from Ozempic® or Wegovy®?
Zepbound and Wegovy are approved by the FDA for weight loss, while Ozempic is approved for the treatment of type 2 diabetes, but can be prescribed off-label for weight loss, if appropriate.
The main difference between these medications is the active ingredient. Ozempic and Wegovy use semaglutide, while Zepbound uses tirzepatide. Tirzepatide is a dual-action GLP-1 and GIP, meaning it works by activating two receptors to curb hunger and regulate your metabolism, helping you feel full faster and longer. In comparison, semaglutide only activates the GLP-1 receptor.
What’s the difference between Zepbound pens and vials?
Zepbound pens and vials are the exact same FDA-approved medications and are available in the same doses. This means that whether you take Zepbound via a syringe or pen, both dosage forms have the same efficacy and side effects. On average, people on Zepbound lose 20% of their weight in a year.*
Key differences:
-
Zepbound vials are administered with a syringe and vial, while Zepound pens are prefilled autoinjector pens.
-
Zepbound vials can be shipped conveniently and directly to you from the LillyDirect partner pharmacy, while Zepbound pens can only be fulfilled through your preferred pharmacy.
-
Zepbound vials are only available as a cash pay offering, and are not eligible for insurance coverage. Zepbound pens are available as a cash pay offering or through insurance coverage.
Reviews
There are no reviews yet.